Clinical Trials in Los Angeles

Showing 3841-3860 of 16,901 trials

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

NCT04902053

The primary objective of the INSPIRIS RESILIA Aortic Valve-in-valve (ViV) Surveillance Study ("the Study") is to capture Adverse Event information and valve measurement data from dysfunctional INSPIRIS RESILIA aortic valves before and after Valve-in-valve (ViV) treatment.

Aortic Valve Replacement

Edwards Lifesciences50 participantsStarted Jun 2028

Los Angeles, California, United States • Gainesville, Florida, United States • Orlando, Florida, United States +4 more locations

Active Not RecruitingPhase 3< 1 mile

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

NCT03635788

The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy (ART) and all-oral standard of care (SOC).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)456 participantsStarted Mar 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +30 more locations

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Find Trials by Condition in Los Angeles

Movement and Fitness Trackers in Determining Performance Status

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

A Study of Abemaciclib in Recurrent Glioblastoma

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

The Care Ecosystem Consortium Effectiveness Study

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD